PMH19 ECONOMIC ASSESSMENT OF SECOND-LINE TREATMENT- SWITCHING FROM A GENERIC SSRI TO ESCITALOPRAM, AN SNRI, OR ANOTHER GENERIC SSRI BY PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
May 1, 2009, 00:00
10.1016/S1098-3015(10)73940-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)73940-1/fulltext
Title :
PMH19 ECONOMIC ASSESSMENT OF SECOND-LINE TREATMENT- SWITCHING FROM A GENERIC SSRI TO ESCITALOPRAM, AN SNRI, OR ANOTHER GENERIC SSRI BY PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73940-1&doi=10.1016/S1098-3015(10)73940-1
First page :
Section Title :
Open access? :
No
Section Order :
418